|
 |
|
      |
|
|
» Apply for a Grant
- FAQs - Young Investigator - Independent Investigator - Distinguished Investigator - Staglin Award » Grantee List - Young Investigators - Independent Investigators - Distinguished Investigators - Staglin Awards
» Prizes
- Lieber Prize - Falcone Prize - Ruane Prize - Goldman-Rakic Prize - Freedman Award - Klerman Award » For Grantees - Young Investigator Fact Sheet - Independent Investigator Fact Sheet - Distinguished Investigator Fact Sheet - Staglin Award Fact Sheet 
|
 Project Summary  David J. Posey, M.D. (Young Investigator 2000) of Indiana University, is conducting a clinical trial of a medication called mirtazapine (Remeron) in patients with autism. This disorder is characterized by severe deficits in social functioning, communication, and behavior. Previous work has shown effectiveness of mirtazapine in the treatment of aggression, agitation, and anxiety. Half of the patients in this study will be administered mirtazapine, and half will receive placebo. The groups will be compared after 8 weeks of treatment to determine which respond to mirtazapine. Program Area: PERVASIVE DEVELOPMENTAL DISORDERS\Autism |
Announcements
NARSAD Award Winners
Latest News from NARSAD
|
Mei Huang, Ph.D., Vanderbilt University Medical Center, 2005 & 2007 Young Investigator